The medtech developer exceeded Wall Street expectations across the board, reporting $19.5 billion in revenue for fiscal year ...

Solventum’s separation from 3M is more than 90% complete following the completion of its planned enterprise resource planning ...

Shareholders of Siemens and Siemens Healthineers will vote on the deconsolidation from Siemens during their annual meetings ...

Smith+Nephew’s CEO confirmed this week that talks failed with Johnson & Johnson over an orthopedic megamerger with DePuy ...

At the TCT conference in San Diego, Medtronic and Recor Medical presented new findings from their rival treatments for high ...

The annual TCT conference in San Diego saw medtechs illustrate methods for controlling stroke, reestablishing coronaries and ...

In the last two quarters, we gained share and our competitive position improved. But we believe that we have reached a ...

Nearly a week after Stryker (NYSE: SYK) reported a tough U.S. health insurance environment for hip and knee procedures, ...

The Vitalyst system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock.

As Medline expects continued net sales growth in 2027, it also plans to implement a prince increase to offset inflation ...

LivaNova posted earnings ahead of Wall Street estimates as it plans to launch its neuromodulation platform for obstructive ...

Philips has reached a settlement with the Department of Justice to tie up the remaining criminal and civil probes into its ...